New York University School of Medicine Listed a New Clinical Trial of Lenvatinib Mesylate and Pembrolizumab in Treating Patients with Metastatic or Recurrent Gastric or Gastroesophageal Cancer

Press/Media

Period29 Jan 2018

Media coverage

1

Media coverage

  • TitleNew York University School of Medicine Listed a New Clinical Trial of Lenvatinib Mesylate and Pembrolizumab in Treating Patients with Metastatic or Recurrent Gastric or Gastroesophageal Cancer
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date29/01/18
    PersonsDeirdre Cohen